Israel’s Angioslide Inks $6.3M
Angioslide, an Israeli developer of "Embolic Capture Angioplasty" technology, has raised $6.3 million in financing led by new investor TriVentures. Return investors Viola Partners, Agate and XT Investments also participated. The Series C round will be used for U.S. expansion, among other growth efforts.
3 January 2013•2 mins read
